文献速递肝胆胰外科胃肠外科

腹腔镜RAMPS治疗胰腺恶性肿瘤初期经验的系统范围综述

A systematic scoping review of the initial experience with laparoscopic radical antegrade modular pancreatosplenectomy for pancreatic malignancy.
PubMed 文献 · Surg Endosc · 2021-05-14

本系统范围综述检索截至2020年9月的文献,纳入8篇小样本回顾性队列共92例腹腔镜RAMPS,无研究直接比较开腹与腹腔镜RAMPS;报道的肿瘤学与安全性结果可接受,但选择标准与结局报告异质,需标准化技术描述与培训。

要点

  • 腹腔镜RAMPS文献稀少,仅8篇回顾性小样本共92例,无与开腹RAMPS的直接对比研究。
  • 报道的R0切除率中位范围91-100%,淋巴结中位范围11-43枚,肿瘤学与安全性结果可接受。
  • 选择标准仅4/8篇报告且各异,技术描述6/8篇,结局报告不统一,需标准化。

核心结论

  • 腹腔镜RAMPS文献报道稀少,暂无数据支持其与开腹RAMPS直接比较。
  • 现有报道显示腹腔镜RAMPS的肿瘤学与安全性结果可接受。
  • 标准化手术技术描述与结局报告及专项培训可能有助于推广腹腔镜RAMPS。

研究设计与样本

  • 系统范围综述,2020年9月检索文献,纳入8篇回顾性小样本队列共92例腹腔镜RAMPS。

主要发现

  • 无研究直接比较开腹与腹腔镜RAMPS,所有报告均为3-30例的小样本回顾性队列。
  • 选择标准在4/8篇研究中报告且各研究不同,技术描述见于6/8篇研究。
  • 研究报道的十项手术与临床结局中位数范围为5项(范围1-9项)。
  • 手术时间中位范围188-431分钟,术中失血中位范围18-445 mL。
  • R0切除率中位范围91-100%,淋巴结中位范围11-43枚,住院时间中位范围12-20天。

关键数值与推荐

  • R0切除率中位范围91-100%,淋巴结获取中位范围11-43枚。
  • 手术时间中位范围188-431分钟,术中失血中位范围18-445 mL。
  • 住院时间中位范围12-20天。

临床怎么用

  • 腹腔镜RAMPS可用于胰腺体尾部恶性肿瘤,但需注意现有证据仅来自小样本回顾性研究。
  • 应关注选择标准、技术细节与结局报告的标准化,并考虑专项培训。

局限性

  • 仅纳入8篇小样本回顾性队列共92例,无对照研究。
  • 选择标准与结局报告异质,技术描述不全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Laparoscopic radical antegrade modular pancreatosplenectomy (L-RAMPS) is a validated surgical approach for the surgical treatment of pancreatic malignancies of the body and tail of the pancreas. Open (O-) RAMPS is an established technique that offers oncological efficacy and acceptable post-operative outcomes when compared to standard distal pancreatectomy for pancreatic malignancies. This review aimed to determine the types of evidence available for L-RAMPS, and its selection criteria and reported outcomes, using systematic scoping review methodology. METHODS: A systematic review of available literature was performed in September 2020. Data extracted included patient selection criteria, technical details, total number of L-RAMPS procedures performed, lymph nodes retrieved, resection margins, survival, LOS and complications. RESULTS: Eight papers were eligible for inclusion, totalling 92 cases. There were no studies that directly compared O- to L-RAMPS. All reports were small retrospective cohorts with 3-30 patients. Selection criteria were reported in 4/8 studies and differed between studies. Technique descriptions were included in 6/8 studies. Studies reported a median of 5 (range 1-9) out of ten operative and clinical outcomes, including operative time median range 188-431 min, intraoperative blood loss median range 18-445 mL, R0 resection rate median range 91-100%, number of lymph nodes median range 11-43, and length of stay median range 12-20 days. CONCLUSIONS: L-RAMPS is infrequently reported in the literature. There are currently no data to allow for direct comparison of O- and L-RAMPS. Reports of L-RAMPS have an acceptable oncological and safety profile. A standardised description of the operative technique and outcome reporting, as well as specific training initiatives may be beneficial to broaden the application of L-RAMPS.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Larkins K, Rowcroft A, Pandanaboyana S, et al. A systematic scoping review of the initial experience with laparoscopic radical antegrade modular pancreatosplenectomy for pancreatic malignancy. Surg Endosc. 2021. PMID: 33988769. doi:10.1007/s00464-021-08528-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。